You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Citation Tools

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Martens AWJ, Janssen SR, Derks IAM, et al
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Journal for ImmunoTherapy of Cancer 2020;8:e000218. doi: 10.1136/jitc-2019-000218